| Primary |
| Osteoarthritis |
20.3% |
| Rheumatoid Arthritis |
12.9% |
| Arthritis |
9.6% |
| Hypertension |
9.6% |
| Back Pain |
9.1% |
| Arthralgia |
7.7% |
| Pain |
6.5% |
| Gastritis |
2.5% |
| Constipation |
2.2% |
| Sciatica |
2.0% |
| Insomnia |
1.9% |
| Depression |
1.9% |
| Hyperlipidaemia |
1.9% |
| Osteoporosis |
1.9% |
| Prophylaxis |
1.9% |
| Gout |
1.8% |
| Spinal Osteoarthritis |
1.6% |
| Type 2 Diabetes Mellitus |
1.6% |
| Blood Cholesterol Increased |
1.6% |
| Bone Pain |
1.6% |
|
| Drug Ineffective |
12.9% |
| Gastrointestinal Haemorrhage |
10.0% |
| Haemorrhage |
6.1% |
| Vomiting |
6.1% |
| Rectal Haemorrhage |
5.5% |
| Renal Impairment |
5.1% |
| Renal Failure Acute |
4.8% |
| Renal Failure |
4.5% |
| Weight Decreased |
4.5% |
| Melaena |
4.2% |
| Nausea |
4.2% |
| Transient Ischaemic Attack |
4.2% |
| Ulcer Haemorrhage |
4.2% |
| Vision Blurred |
4.2% |
| Myocardial Infarction |
3.9% |
| Death |
3.5% |
| Ulcer |
3.2% |
| Upper Gastrointestinal Haemorrhage |
3.2% |
| Anaemia |
2.9% |
| Hypertension |
2.9% |
|
| Secondary |
| Arthritis |
13.9% |
| Pain |
13.2% |
| Rheumatoid Arthritis |
12.7% |
| Product Used For Unknown Indication |
7.6% |
| Musculoskeletal Pain |
5.7% |
| Osteoarthritis |
5.5% |
| Hypertension |
5.5% |
| Back Pain |
4.7% |
| Drug Use For Unknown Indication |
3.9% |
| Inflammation |
3.8% |
| Oedema Peripheral |
3.6% |
| Joint Swelling |
3.3% |
| Arthralgia |
3.3% |
| Osteoporosis |
3.1% |
| Atrial Fibrillation |
2.0% |
| Constipation |
2.0% |
| Depression |
1.8% |
| Fibromyalgia |
1.6% |
| Gastritis |
1.5% |
| Cancer Pain |
1.3% |
|
| Drug Hypersensitivity |
16.7% |
| Interstitial Lung Disease |
7.8% |
| Ulcer |
7.8% |
| Vomiting |
6.6% |
| Upper Gastrointestinal Haemorrhage |
5.0% |
| Gastrointestinal Haemorrhage |
4.7% |
| Weight Decreased |
4.7% |
| Weight Increased |
4.7% |
| Melaena |
4.3% |
| Nausea |
4.3% |
| Vision Blurred |
4.3% |
| Pain |
3.9% |
| Stevens-johnson Syndrome |
3.9% |
| Gastric Ulcer |
3.5% |
| Myocardial Infarction |
3.5% |
| Renal Failure Acute |
3.5% |
| Drug Ineffective |
3.1% |
| Pneumonia Cytomegaloviral |
2.7% |
| Rash |
2.7% |
| Squamous Cell Carcinoma |
2.7% |
|
| Concomitant |
| Product Used For Unknown Indication |
21.0% |
| Rheumatoid Arthritis |
19.6% |
| Drug Use For Unknown Indication |
11.9% |
| Hypertension |
7.3% |
| Pain |
7.0% |
| Osteoporosis |
3.9% |
| Depression |
3.2% |
| Arthritis |
3.1% |
| Prophylaxis |
3.0% |
| Gastrooesophageal Reflux Disease |
2.6% |
| Back Pain |
2.1% |
| Insomnia |
2.0% |
| Diabetes Mellitus |
1.9% |
| Anxiety |
1.8% |
| Fibromyalgia |
1.8% |
| Osteoarthritis |
1.7% |
| Asthma |
1.6% |
| Constipation |
1.6% |
| Psoriatic Arthropathy |
1.6% |
| Arthralgia |
1.5% |
|
| Vomiting |
11.2% |
| Weight Decreased |
10.2% |
| Weight Increased |
9.2% |
| Pain |
6.7% |
| Nausea |
5.7% |
| Drug Ineffective |
5.4% |
| Pneumonia |
4.6% |
| Injection Site Pain |
4.5% |
| Pyrexia |
4.5% |
| Rash |
4.1% |
| Urinary Tract Infection |
4.1% |
| Somnolence |
3.8% |
| Vision Blurred |
3.8% |
| Pain In Extremity |
3.4% |
| White Blood Cell Count Decreased |
3.4% |
| Myocardial Infarction |
3.4% |
| Tremor |
3.3% |
| Thrombocytopenia |
3.1% |
| Pruritus |
2.9% |
| Wound Infection Staphylococcal |
2.9% |
|
| Interacting |
| Drug Use For Unknown Indication |
20.0% |
| Pain |
16.7% |
| Ill-defined Disorder |
10.0% |
| Product Used For Unknown Indication |
10.0% |
| Cardiovascular Event Prophylaxis |
6.7% |
| Deep Vein Thrombosis |
6.7% |
| Sleep Disorder |
6.7% |
| Arthralgia |
3.3% |
| Asthma |
3.3% |
| Fibromyalgia |
3.3% |
| Headache |
3.3% |
| Hypertension |
3.3% |
| Osteoarthritis |
3.3% |
| Type 2 Diabetes Mellitus |
3.3% |
|
| Colitis |
22.2% |
| Drug Interaction |
11.1% |
| Gastrointestinal Haemorrhage |
11.1% |
| Hypertension |
11.1% |
| Insomnia |
11.1% |
| Pain In Extremity |
11.1% |
| Renal Disorder |
11.1% |
| Vomiting |
11.1% |
|
